Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuroone Medical Technologies (NMTC) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for Neuroone Medical Technologies (NMTC) over the last 14 years, with Q4 2025 value amounting to $147823.0.

  • Neuroone Medical Technologies' Cash from Financing Activities rose 12902.33% to $147823.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $8.7 million, marking a year-over-year increase of 5636.57%. This contributed to the annual value of $8.0 million for FY2025, which is 1045.13% up from last year.
  • According to the latest figures from Q4 2025, Neuroone Medical Technologies' Cash from Financing Activities is $147823.0, which was up 12902.33% from $66978.0 recorded in Q3 2025.
  • Over the past 5 years, Neuroone Medical Technologies' Cash from Financing Activities peaked at $12.0 million during Q4 2021, and registered a low of -$509325.0 during Q4 2024.
  • Over the past 5 years, Neuroone Medical Technologies' median Cash from Financing Activities value was $933487.5 (recorded in 2023), while the average stood at $2.3 million.
  • As far as peak fluctuations go, Neuroone Medical Technologies' Cash from Financing Activities skyrocketed by 20567795.03% in 2023, and later crashed by 14226.71% in 2024.
  • Quarter analysis of 5 years shows Neuroone Medical Technologies' Cash from Financing Activities stood at $12.0 million in 2021, then plummeted by 100.13% to -$15713.0 in 2022, then skyrocketed by 7768.9% to $1.2 million in 2023, then crashed by 142.27% to -$509325.0 in 2024, then skyrocketed by 129.02% to $147823.0 in 2025.
  • Its Cash from Financing Activities stands at $147823.0 for Q4 2025, versus $66978.0 for Q3 2025 and $8.2 million for Q2 2025.